Julia Cheek is the CEO and founder of Everlywell, the digital health company poised to disrupt the 25 billion dollar lab testing industry by providing consumers with at-home testing kits that include insightful, easy-to-understand results. Founded in 2015, the company has raised $50 million in funding, scaled to tens of millions in sales, and is now sold in Target and CVS stores nationwide. Everlywell has earned a variety of industry accolades from AdAge, Business Insider and Techcrunch and was named one of Fast Company’s Most Innovative Companies in 2019. 

Before founding Everlywell, Julia worked in corporate development and strategy after attending Vanderbilt University and graduating from Harvard Business School as a Baker Scholar with high distinction. A seasoned entrepreneur who has taken the stage at conferences like Fortune’s Most Powerful Women Summit and SXSW, she is passionate about two things: increasing accessibility in healthcare and inspiring the next generation of women leaders. In 2020, she was named one of the 100 women breaking glass ceilings and changing the world by Create & Cultivate and was named one of Fortune Magazine’s 40 Under 40 for her work to fight the coronavirus pandemic. She also sits on a variety of boards, including the Digital Health Advisory Board for biopharmaceutical company AstraZeneca.